Letter on Strengthening the Pan-Canadian Public Health System ...

Review of Controlled Drugs and Substances Act: Canadian ...

Response to the consultation paper Pension Innovation for ...

Proposed amendments to the marihuana for medical purposes ...

Tamper Resistance under the Controlled Drugs and Substances ...

CMA's Response to Health Canada's Public Consultation Guide ...

Regulatory framework for the mandatory reporting of adverse ...

Consultation on the prescription drug list: Naloxone

Legalization, regulation and restriction of access to marijuana

Avoiding negative consequences to health care delivery from ...

CMA response to patented medicines regulations consultations

Non-prescription availability of low-dose codeine products

Excise duty framework for cannabis products

Front-of-package labelling consultation

Regulation of Self-Care Products in Canada

Consultation on the renewal of Federal Tobacco Control ...

Health Canada’s Consultation on “Plain and Standardized Packaging”

Proposed approach to the regulation of cannabis

Federal Monitoring and Reporting Regime for MAID

Federal monitoring of medical assistance in dying regulations